BiroDEShalitaAR. Clinical aspects of topical retinoids. Skin Pharmacol1993; 6(Suppl l):53–60.
4.
ShalitaAWeissJSChalkerDK. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.25% in the treatment of acne vulgaris. A multicenter trial. J Am Acad Dermatol1996; 34:482–485.
5.
BernsteinJEShalitaAR. Topically applied erythromycin in inflammatory acne vulgaris. J Am Acad Dermatol1980; 2:318–321.
6.
ShalitaARSmithEBBauerE. Topical erythromycin vs clindamycin therapy for acne. A multicenter, double-blind comparison. Arch Dermatol1984; 120:351–355.
7.
LeydenJJShalitaARSaatjianGDSeftonJ. Erythromycin 2% gel in comparison with clindamycin phosphate 1 % solution in acne vulgaris. J Am Acad Dermatol1987; 16:822–827.
8.
BernsteinJEShalitaAR. Effects of topical erythromycin on aerobic and anaerobic surface flora. Acta Derm Venereol1980; 60:537–538.
9.
LeeWLShalitaAR. Neutrophil Chemotaxis by Propionibacterium acnes lipase and its inhibition. Immunology1982; 35:71–78.
10.
ChalkerDFShalitaARSmithJG. A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol1983; 9:933–936.
11.
HarkawayKSMcGinleyKJFogliaAN. Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br J Dermatol1992; 126:586–590.